| A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19 (NCT05981846) | Hipra Scientific, S.L.U | 2023-09-04 |
| Hetrombopag in Secondary Prevention of XPO-1 Inhibitor-induced Thrombocytopenia in Lymphoma (NCT05969158) | Sun Yat-sen University | 2023-09-04 |
| Immunologic Changes and Recovery-related Factors in Elderly Colon Cancer Patients (NCT06454071) | Soonchunhyang University Hospital | 2023-09-04 |
| Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis) (NCT06006689) | Tasly Pharmaceutical Group Co., Ltd | 2023-09-04 |
| Niraparib Maintenance Treatment in mCRC With a Partial o Complete Response After Oxaliplatin-based Induction Therapy (NCT05412706) | Ospedale Policlinico San Martino | 2023-09-04 |
| A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes (NCT05693909) | Pharmacosmos A/S | 2023-09-04 |
| Induction Chemotherapy and Tazemetostat for Locally Advanced SMARCB1-deficient Sinonasal Carcinoma (NCT05151588) | Dr. Victor H.F. Lee | 2023-09-01 |
| The Application of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Surface Malignancies (NCT06367270) | The University of Hong Kong | 2023-09-01 |
| The Safety and Efficacy of MSC-EVs in Acute/Acute-on-Chronic Liver Failure (NCT05940610) | Third Affiliated Hospital, Sun Yat-Sen University | 2023-09-01 |
| Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma (NCT05996484) | Nanfang Hospital, Southern Medical University | 2023-09-01 |
| Does Non-Steroidal Anti-inflammatory Drugs Decrease the Quality of Pleurodesis After Mechanical Pleural Abrasion/Pleurectomy for Treatment of Pneumothorax? (NCT06467318) | Ain Shams University | 2023-09-01 |
| Spinal Cord Innovation in Pediatrics (SCiP) to Treat SensoriMotor Function in Children Cerebral Palsy: Protocol for a Randomized Controlled Trial (NCT05720208) | SpineX Inc. | 2023-09-01 |
| Acute Effects of Furosemide on Hemodynamics and Pulmonary Congestion in Acute Decompensated Heart Failure. (NCT06024889) | Johannes Grand | 2023-09-01 |
| Phase I/II Study of αPD1-MSLN-CAR T Cells in MSLN-positive Advanced Solid Tumors (NCT05944185) | Shanghai Cell Therapy Group Co.,Ltd | 2023-09-01 |
| Sodium Valproate in Patients With Acute Ischemic Stroke (NCT06020898) | RenJi Hospital | 2023-09-01 |
| Evaluating Rapamycin Treatment in Alzheimer's Disease Using Positron Emission Tomography (NCT06022068) | Karolinska Institutet | 2023-09-01 |
| Impact of Vitamin D Supplementation on Fetomaternal Outcomes in LTBI Pregnant Females (NCT06354621) | University of the Punjab | 2023-09-01 |
| The Safety and Efficacy of Zanubrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia (NCT06021977) | Institute of Hematology & Blood Diseases Hospital, China | 2023-09-01 |
| Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer (NCT05502913) | Soroka University Medical Center | 2023-09-01 |
| Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder (NCT05416229) | Anders Fink-Jensen, MD, DMSci | 2023-09-01 |
| Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans (NCT05173831) | Resilient Pharmaceuticals | 2023-09-01 |
| Effectiveness of Apheresis Platelet-Rich Plasma Injection for Androgenic Alopecia (NCT07348315) | zhang li | 2023-09-01 |
| Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV (NCT05514899) | University of California, San Diego | 2023-09-01 |
| Large Linguistic Model for Clinical Reaoning of Physical Therapy Students (NCT06809634) | Neuron, Spain | 2023-09-01 |
| Topical Steroids & Bacterial Decolonization for Radiation Dermatitis (NCT05505214) | Montefiore Medical Center | 2023-09-01 |
| PTH-independent Effects of Encaleret (NCT05735015) | National Institute of Dental and Craniofacial Research (NIDCR) | 2023-09-01 |
| A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy (NCT06208826) | Tianjin Medical University Cancer Institute and Hospital | 2023-09-01 |
| Effectiveness and Safety of Shaoyao Gancao Decoction With Addition on the Sleep-related Leg Cramps (NCT05980637) | Chinese University of Hong Kong | 2023-09-01 |
| Efficacy and Toxicity of Total Neoadjuvant Sandwich Treatment Via Short Course Radiotherapy in the Treatment of Stage II and III Rectal Cancer Patients (NCT07095439) | Ain Shams University | 2023-09-01 |
| Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer (NCT05983094) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-09-01 |
| GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial (NCT05693545) | Children's Hospital Medical Center, Cincinnati | 2023-09-01 |
| An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001) (NCT05879614) | Neuren Pharmaceuticals Limited | 2023-09-01 |
| CD62L Depleted Donor Lymphocyte Infusion With T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation (NCT06034535) | Hong Kong Children's Hospital | 2023-09-01 |
| Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation (NCT06041490) | Peking Union Medical College Hospital | 2023-09-01 |
| Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma (NCT05937438) | Anhui Provincial Hospital | 2023-09-01 |
| Total Neoadjuvant Chemoradiotherapy Plus Anti-PD-1 in Subperitoneal Patients With Locally Advanced Rectal CancerPatients With Locally Advanced Rectal Cancer: A Prospective, Single Arm, Exploratory Study (NCT05998122) | The First Hospital of Jilin University | 2023-09-01 |
| Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC (NCT06138496) | Sun Yat-sen University | 2023-09-01 |
| Analysis of the Effect of Neuromuscular Electro-stimulation on the Performance of Isometric Rotator Cuff Strength. (NCT06023914) | University of Campinas, Brazil | 2023-09-01 |
| Adelbelimab Combination Chemotherapy in Neoadjuvant Therapy for Squamous Cell Carcinoma of the Head and Neck (NCT06016413) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-09-01 |
| Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004) (NCT06130332) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-09-01 |
| A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma (NCT05976568) | Qilu Pharmaceutical Co., Ltd. | 2023-09-01 |
| Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients (NCT06492798) | Changhai Hospital | 2023-09-01 |
| Study to Evaluate the Ability of Sublingual MV130 to Induce the Expression of Trained Immunity in Peripheral Blood Cells (NCT05208060) | Inmunotek S.L. | 2023-09-01 |
| Normal Saline Infusion for Stroke After Intravenous Thrombolysis (NCT05993078) | Tianjin Medical University General Hospital | 2023-09-01 |
| Prophylactic Antibiotics Duration Towards Healing and Risk of Infection in Permanent Pacemaker (PPM) Installation (NCT06355115) | University of Brawijaya | 2023-09-01 |
| Improvement of Organ Function by Apigenin in Elderly Patients With Sepsis (NCT05999682) | Zhujiang Hospital | 2023-09-01 |
| To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-M (NCT05733780) | Bioxytran Inc. | 2023-09-01 |
| The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19 (NCT04798716) | AVEM HealthCare | 2023-09-01 |
| Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery (NCT06209294) | Xiaohua Wu | 2023-09-01 |
| Long Term Clinical Efficacy of Sodium-glucose Cotransporter-2 (SGLT-2) Inhibitor in Cystinurics (NCT05058859) | University of California, San Francisco | 2023-09-01 |
| Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19 (NCT04428801) | Celltex Therapeutics Corporation | 2023-09-01 |
| Ketamine for the Treatment for Alcohol Use Disorder in the ED (NCT05661669) | Brigham and Women's Hospital | 2023-09-01 |
| Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma (NCT06115408) | Ain Shams University | 2023-09-01 |
| Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer (NCT05479240) | Fujian Cancer Hospital | 2023-09-01 |
| Cadonilimab Plus Regorafenib and Gem-Cis Chemotherapy in Advanced Biliary Tract Cancer (NCT05820906) | Tianjin Medical University Cancer Institute and Hospital | 2023-09-01 |
| Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT05807880) | Sun Yat-sen University | 2023-09-01 |
| A Pilot Study of Circulating Tumor DNA Adaptive Risk Maintenance Approach for Bladder Cancer (CARMA) (NCT06050954) | Fox Chase Cancer Center | 2023-09-01 |
| the Effect of Hyaluronic Acid Intrauterine Wash on Endometrial Receptivity and Pregnancy Outcome (NCT06937645) | Al-Nahrain University | 2023-09-01 |
| Study of Selinexor Combined With Olaparib in Relapsed/Refractory Extensive Stage Small Cell Lung Cancer (NCT05975944) | Tianjin Medical University Cancer Institute and Hospital | 2023-09-01 |
| Part II: Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia (NCT04373941) | Holterman, Ai-Xuan, M.D. | 2023-09-01 |
| Study to Assess PXL770 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD) (NCT05146284) | Poxel SA | 2023-09-01 |
| Phase II Study of Reuse of Oxaliplatin Hypersensitivity in Gastrointestinal Tumors (NCT05922358) | Fujian Cancer Hospital | 2023-09-01 |
| The Proposed Study Aims to Investigate the Impact of Adjunctive Vitamin D Gel Application on Gingival Crevicular Fluid Levels of Alkaline Phosphatase and Interleukin-8 in Periodontitis Patients Undergoing Phase 1 Periodontal Therapy. By Elucidating the Molecular Mechanisms Underlying the Therapeutic (NCT06669026) | Mansoura University | 2023-09-01 |
| De-escalation of Neoadjuvant Treatment (Paclitaxel + HP) in Early HER2+ Breast Cancer (NCT07421141) | National Medical Research Radiological Centre of the Ministry of Health of Russia | 2023-09-01 |
| Combining Intratumoral Flu Vaccine and Systemic Pembrolizumab in Patients With Early pMMR Colorectal Cancer (NCT05909423) | Zealand University Hospital | 2023-09-01 |
| SPEARHEAD-3 Pediatric Study (NCT05642455) | USWM CT, LLC | 2023-09-01 |
| Efficacy of Bushen Huatan Decoction in the Treatment of Polycystic Ovary Syndrome (NCT05976308) | Jiangxi University of Traditional Chinese Medicine | 2023-09-01 |
| Enhancing Work Participation of Unemployed and Work-Disabled Cancer Survivors (NCT06028048) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2023-09-01 |
| Radiotherapy Combined With Almonertinib for Stage III EGFR-Mutated Lung Cancer (NCT05994339) | Laibin People's Hospital | 2023-09-01 |
| Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma (NCT05525273) | Eva Marie Erfurth, MD, PhD | 2023-09-01 |
| Lazertinib and Chemotherapy Combination in EGFR-mutant NSCLC Patients Without ctDNA Clearance After lead-in Lazertinib Monotherapy (NCT06020989) | Yonsei University | 2023-09-01 |
| Study to Assess PXL065 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD) (NCT05200104) | Poxel SA | 2023-09-01 |
| Cadonilimab/Anlotinib in Locally Advanced or Relapsed/Metastatic ESCC Patients After Failure of PD-1 Combined With Platinum-containing Chemotherapy (NCT05990231) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-09-01 |
| Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001) (NCT05891821) | Immune Oncology Research Institute | 2023-09-01 |
| Plerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCT (NCT06141304) | The First Hospital of Jilin University | 2023-09-01 |
| Short-course Radiotherapy Combined With Furoquintinib and PD-1 Monoclonal Antibody (NCT06014944) | Changhai Hospital | 2023-09-01 |
| Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNoma (NCT06341764) | National Cancer Institute, Naples | 2023-09-01 |
| Intranasal Cocaine and Temperature Regulation During Exercise (NCT05809453) | University of Texas Southwestern Medical Center | 2023-09-01 |
| Lenvatinib, Tislelizumab Combined With RALOX Regimen HAIC in Advanced Hepatocellular Carcinoma (NCT05954897) | Guangdong Provincial People's Hospital | 2023-09-01 |
| A Novel Wearable Device to Improve Sleep Quality (NCT05952297) | University of Utah | 2023-09-01 |
| Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial (NCT06031285) | Sun Yat-sen University | 2023-09-01 |
| A Crossover Bioavailability Clinical Trial of Parenteral Pyronaridine and Artesunate (NCT05929157) | Centre de Recherche Médicale de Lambaréné | 2023-09-01 |
| Efficacy of Jianpi Qushi Huatan Decoction in the Treatment of Polycystic Ovary Syndrome (NCT05976295) | Jiangxi University of Traditional Chinese Medicine | 2023-08-31 |
| A Phase Ib/II Clinical Trial of PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor (NCT06026501) | Shanghai YingLi Pharmaceutical Co. Ltd. | 2023-08-31 |
| FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients (NCT06604260) | Dalia Lartey | 2023-08-31 |
| Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab. (NCT05788081) | Olivia Newton-John Cancer Research Institute | 2023-08-31 |
| SA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 Patients (NCT06042764) | Sinovac Life Sciences Co., Ltd. | 2023-08-31 |
| Venetoclax After TKI to Target Persisting Stem Cells in CML (NCT05701215) | Thomas Ernst, PD Dr. med. | 2023-08-31 |
| A Study of HS-10353 in Adult Participants With Major Depressive Disorder (NCT05938179) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2023-08-31 |
| VK2735 for Weight Management Phase 2 (NCT06068946) | Viking Therapeutics, Inc. | 2023-08-31 |
| Study to Investigate the Chemotherapy-Induced Peripheral Neuropathy (CIPN) Onset-Suppressing Effect and Safety of ONO-2910 in Patients With Breast Cancer Receiving Weekly Paclitaxel (NCT06538272) | Ono Pharmaceutical Co., Ltd. | 2023-08-31 |
| Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive Therapy (NCT05323617) | Amgen | 2023-08-31 |
| TXA127 in Non-Ambulant Patients With DMD Cardiomyopathy (NCT06013839) | Constant Therapeutics LLC | 2023-08-31 |
| Selumetinib in Chinese Paediatric With Post-operative NF1-PNs, PhaseⅡ, Double-Blinded, Placebo-Controlled Study (NCT05825365) | AstraZeneca | 2023-08-31 |
| Screening Trial for Pain Relief in Schwannomatosis (STARFISH) (NCT05684692) | Massachusetts General Hospital | 2023-08-31 |
| HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP (NCT05883748) | Disc Medicine, Inc | 2023-08-31 |
| A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR) (NCT06041269) | AnaptysBio, Inc. | 2023-08-31 |
| Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure (NCT06413017) | Tianjin Medical University Cancer Institute and Hospital | 2023-08-31 |
| Endotype-Targeted Therapy to Rescue OSA Patients Struggling With CPAP Adherence (TOP-CPAP) (NCT05951023) | University of California, San Diego | 2023-08-31 |
| Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas (NCT05580588) | Shanghai Pharma Biotherapeutics USA Inc. | 2023-08-31 |